(Q44013141)

28 November 2017

Human ovarian tissue cryopreservation: indications and feasibility (English)

1 reference

28 November 2017

0 references

Catherine Poirot

1

1 reference

28 November 2017

Marie-Cécile Vacher-Lavenu

2

1 reference

28 November 2017

Pierre Helardot

3

1 reference

28 November 2017

Juliette Guibert

4

1 reference

28 November 2017

Laurence Brugières

5

1 reference

28 November 2017

Pierre Jouannet

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

28 November 2017

1 reference

28 November 2017

17

1 reference

28 November 2017

6

1 reference

28 November 2017

1447-1452

1 reference

Infertility and premature menopause in childhood cancer survivors

28 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

Development of oocyte banks and systems for the in-vitro development of oocytes: future directions for the treatment of infertility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

Pregnancy after human oocyte cryopreservation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

Childhood cancer: improved prospects for survival but is prevention possible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

Human oocyte cryopreservation: new perspectives regarding oocyte survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

Cryopreservation of human ovarian tissue using dimethylsulphoxide and propanediol-sucrose as cryoprotectants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

Cryopreservation in human assisted reproduction is now routine for embryos but remains a research procedure for oocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

Reproduction post-chemotherapy in young cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

Permeation of human ovarian tissue with cryoprotective agents in preparation for cryopreservation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

Ovarian tissue cryopreservation and transplantation: preliminary findings and implications for cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

Proliferating cell nuclear antigen marks the initiation of follicular growth in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

Cryopreservation of immature human oocytes and ovarian tissue: an emerging technology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

Reproductive technologies 1998: options available for the cancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

Outcome assessment in cancer management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

The adverse effects of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.6.1447

21 January 2018

Identifiers

DOI

10.1093/HUMREP/17.6.1447

1 reference

28 November 2017

1 reference